Compounds > phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide

phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide and cholecystokinin

phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide has been researched along with cholecystokinin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, C; Benoliel, JJ; Cesselin, F; Hamon, M1

Other Studies

1 other study(ies) available for phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide and cholecystokinin

ArticleYear
Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
    Synapse (New York, N.Y.), 1999, Volume: 34, Issue:1

    Topics: Analgesics, Opioid; Animals; Cholecystokinin; Extracellular Space; Injections; Ligands; Male; Microdialysis; Morphine; Naltrexone; Narcotic Antagonists; Prefrontal Cortex; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Somatostatin

1999